Delivery Order SPE2DR25D2005-SPE2DR26FE8C2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at approximately $13,969 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,700.52 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) valued at $20,196.06 under a firm fixed-price contract. This non-set-aside award was issued on December 1, 2025, with an ultimate completion date of December 2, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Vemlidy is an antiviral medication used in hepatitis B treatment, consistent with...
- The Defense Logistics Agency awarded a $3,914.81 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in hepatitis B treatment, representing part of the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $134,109.38 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract calls for performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $5,870.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) with an ultimate completion date of October 20, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $7,426.36 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Vemlidy 25 mg on November 4, 2025, with completion scheduled for November 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply agreement with DLA. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,656.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units). This contract was competitively awarded with firm fixed pricing and no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of May 14, 2025. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,642.26 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count unit). This firm fixed-price contract, awarded on August 29, 2025, with completion targeted for September 2, 2025, represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE8C2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,871.77 to AmerisourceBergen Drug Corp for 30 units of Vemlidy 25 mg tablets, with completion scheduled for December 5, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Vemlidy, an antiviral medication, falls within the extensive therapeutic portfolio the company provides to federal customers including the Defense Health Agency and other government healthcare systems through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 12/3/25 |